SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

CLS Launches SoCal-Focused FAST

STARTUPS: Program Serves Earliest-Stage Biotech Companies

Biotech startups in Southern California will soon have the opportunity to speed up their path to commercialization.

$1B Acquisition for ResMed

SOFTWARE: German SaaS Provider Complements Offerings

ResMed (NYSE: RMD) announced on Tuesday (June 14) that it has entered an agreement to buy MEDIFOX DAN, a privately held German company specializing in out-of-hospital software solutions, for $1 billion.

CB Therapeutics Patents 'Magic' Mushroom Process

PHARMA: Company Makes Psychedelics Sustainable, Scalable

CB Therapeutics is bringing a bit of scientific “magic” of its own to the growing field of “magic” mushroom and other natural psychedelic compounds research.

Entos Pharma Moves into Torrey Pines Life Science Campus

BIOTECH: San Diego Now Canadian Firm’s US HQ

A Canadian pharmaceutical company – Entos Pharmaceuticals – has moved its U.S. operations to a Torrey Pines life science campus after starting them in a nearby incubator.

Tease photo

ResMed in $1B Deal to Acquire German SaaS Firm

ResMed (NYSE: RMD) announced on Tuesday (June 14) that it has entered an agreement to buy MEDIFOX DAN, a German company specializing in out-of-hospital software solutions, for $1 billion.

Scripps Offers Open-Source RNA Drug Development App

BIOTECH: Software Speeds up Process for Future Vaccines

Scripps Research is helping fellow scientists everywhere speed up the process of studying RNA for drug development. Last month, Scripps announced it had created an app named “Pytheas” for studying RNA molecules and that it would be offered to the scientific and academic communities for free as an open-source software tool.

Tease photo

Bristol Myers Squibb Buys Turning Point

BIOTECH: $4.1B Deal Expands ‘Oncology Franchise’

Bristol Myers Squibb (BMS) is further strengthening its ties to San Diego. On June 3, the New York-based global biopharmaceutical company announced it had acquired Turning Point Therapeutics, Inc., a clinical-stage precision oncology company based in San Diego.

Illumina CFO Samad Stepping Down

San Diego-based Illumina (NASDAQ: ILMN) has announced that its CFO, Sam Samad, will be leaving the company next month.

Pleno ‘Hypercoding’ Poised to Disrupt Clinical Testing

BIOTECH: Company Raises $15M Pre-Series A

Multi-omic instrument platform company Pleno, Inc. is poised to disrupt clinical testing.

Sharp Launches Funding Campaign at Groundbreaking

HEALTHCARE: Expansion at Serra Mesa Hospital Part of ‘ENVISION’

Sharp HealthCare is already bringing its “ENVISION” to life. On May 26, the Foundations of Sharp HealthCare broke ground on Sharp Memorial Hospital’s emergency and trauma center expansion – and used the occasion to announce a $250 million fundraising campaign to advance improvements at Sharp’s corporate headquarters, regional medical centers and specialty hospitals.

Illumina Supports Early STEM Education

BIOTECH: Firm’s DNA Sequencing Display Debuts at JA’s BizTown

Illumina, a San Diego stalwart since 1998, now has a high-profile presence at the McGrath Family JA BizTown in the Grantville community.

Tease photo

Bioscience Finance Officers to Convene in San Diego

EVENT: National Conference Held Amidst Industry’s Changing Economy

After two years of pandemic delays, the Association of Bioscience Financial Officers (ABFO) will finally hold its national conference in San Diego next week (June 5-8).

San Diego Tops in Office-to-Lab Conversions

San Diego is the second busiest region in the country when it comes to converting traditional office space to life science labs, according to a report by the commercial real estate brokerage CBRE.

Scripps to Lead Major Antiviral Push

PHARMA: $67M NIH Program Includes 16 U.S. Research Institutes

The National Institute of Allergy and Infectious Diseases (NIAID) announced earlier this month (May 18) it was sponsoring a major new antiviral drug development center to be led by La Jolla-based Scripps Research.

Tease photo

Travel Nurses Ease Critical Hospital Demand

HEALTHCARE: ‘Heroes in the Hotspots’

Demand for traveling nurses has slackened since the peak of the COVID-19 pandemic but staffing companies that represent the nurses said the demand remains high with far more openings than nurses to take them.

Prev